Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

14.50p
   
  • Change Today:
    -0.25p
  • 52 Week High: 47.50
  • 52 Week Low: 7.75
  • Currency: UK Pounds
  • Shares Issued: 245.63m
  • Volume: 73,841
  • Market Cap: £35.62m
  • RiskGrade: 532

Futura Medical sees 'good progress' despite regulatory delays

By Iain Gilbert

Date: Monday 24 Jun 2019

LONDON (ShareCast) - (Sharecast News) - Pharmaceutical company Futura Medical told investors at its annual general meeting on Monday that it had continued to make "good progress" in developing and commercialising its pipeline of product opportunities despite regulatory delays to the advancement of its pain relief gel.
Futura's novel topical pain relief gel TPR100 saw the UK Medicines and Healthcare products Regulatory Agency raise a number of questions requiring additional lab work to be conducted but has also received expressions of interest from a number of parties requesting the group expand its geographical reach.

Elsewhere, the AIM-listed group said it remained "on track" to deliver headline data from its first European Phase 3 study on MED2005, a topical gel for erectile dysfunction, by the end of 2019 - with planning for a second, confirmatory Phase 3 study already underway.

The second study will incorporate a US patient cohort, which Futura expects to facilitate regulatory filing in the US, and will be informed by the receipt and analysis of the first Phase 3 data.

Chairman John Clarke said: "We continue to make good progress in the development and commercialisation of our pipeline of product opportunities.

"We look forward to updating the market on Futura's developments during 2019, which I expect to be a year of very significant progress for the company."

As of 0925 BST, Futura shares had dipped 6.15% to 30.50p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Futura Medical Market Data

Currency UK Pounds
Share Price 14.50p
Change Today -0.25p
% Change -1.69 %
52 Week High 47.50
52 Week Low 7.75
Volume 73,841
Shares Issued 245.63m
Market Cap £35.62m
RiskGrade 532

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
49.01% below the market average49.01% below the market average49.01% below the market average49.01% below the market average49.01% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Price Trend
26.44% below the market average26.44% below the market average26.44% below the market average26.44% below the market average26.44% below the market average
50.88% below the sector average50.88% below the sector average50.88% below the sector average50.88% below the sector average50.88% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 03-Jul-2020

Time Volume / Share Price
10:23 2,000 @ 14.55p
09:29 3,007 @ 14.75p
09:10 2,000 @ 14.55p
09:06 1,500 @ 14.60p
09:05 1,500 @ 14.15p

Futura Medical Key Personnel

CEO James Henry Barder
Finance Director Angela Hildreth

Top of Page